Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs Beclomethasone on Linear Growth in Pediatric Mild Asthma
NCT00395408Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2000
- Primary completion
- Dec 2003
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of montelukast in asthma (3 arms), sponsored by Organon & Co. Primary endpoint: Average rate of linear growth at 56 weeks. Started Jun 2000; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00395408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395408.